Flavonifractor plautii: A rare pathogen in sepsis and critical care---A systematic narrative review of literature
Abstract
BACKGROUND: Sepsis, a leading cause of mortality, is commonly caused by bacterial infections. Flavonifractor plautii is a rare anaerobic, gram-positive rod bacterium that forms part of the human intestinal microbiota. This narrative review aims to summarize patient characteristics, diagnostic approaches, and antibiotic therapy in patients with F plautii infections, with a particular focus on its role as a potential pathogen in sepsis, in order to inform clinical decision-making. METHODS: The investigators conducted a systematic search of PubMed, MEDLINE and Embase databases to identify case reports and cohort studies involving F plautii. RESULTS: A wide range of comorbidities were observed, with immunocompromised patients predominating. Most infections originated from gastrointestinal tract and commonly presented as sepsis. Intensive care unit management was required in 8 of the 11 case reports. In all the cases, the pathogen was isolated from blood cultures, and in some reports additionally from cerebrospinal, pleural and synovial fluid. Antibiotic therapy varied, with meropenem and metronidazole being the most commonly used agents, despite antibiotic resistance was rare. DISCUSSION: F plautii should be considered a potential pathogen in immunocompromised patients presenting with abdominal infections and sepsis. CONCLUSIONS: This review illustrates F plautii`s ability to cause severe sepsis. No specific treatment recommendations beyond current sepsis guidelines were…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.